News

St. Jude Medical Nanostim Leadless Pacemaker EP Lab Clinical Trial

St. Jude Medical selected Dignity Health Sequoia Hospital's Heart and Vascular Institute and Silicon Valley Cardiology to participate in a ...

St. Jude Medical Nanostim Leadless Pacemaker EP Lab

The first U.S. implant was announced for St. Jude Medical’s LEADLESS II pivotal trial, designed to evaluate the...

Biotronik ProMRI Clinical Study Pacemaker EP Lab Magnetic Resonance Imaging

Biotronik enrolled the first patients in an expansion of their ongoing ProMRI trial to test its ...

St. Jude Medical Nanostim Leadless Pacemaker EP Lab

Prof. Richard Schilling implanted St. Jude Medical Inc.’s Nanostim retrievable leadless pacemaker at St....

The Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics (TCT) 2013 offers many new insights about the latest cardiovascular technologies and treatment techniques. These...

ACC, iPad cardiology apps

DAIC readers chose the following stories as the most popular content in 2013, based on website analytics.

nanostim pacemaker, SJM

The tiny device, about the size of the head of a pen, can be delivered via a delivery catheter through the venous system and placed directly into the myocardium of the right ventricle. 

nanostim pacemaker, SJM

St. Jude Medical Inc. announced the completion of its acquisition of Nanostim Inc., developer of a miniaturized, leadless pacemaker, and that the device received CE mark clearance in Europe....

The U.S. Food and Drug Administration (FDA) announced a final rule for the unique device identification system (UDI) that, once implemented, will provide a consistent way to identify...

Nanostim, leadless pacemaker

There have been several advances in electrophysiology (EP) technologies this past year, many of which were highlighted during the Heart Rhythm Society (HRS) 2013 scientific sessions earlier this...

July 25, 2013 — The 2013 ESC (European Society of Cardiology) Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy, developed in collaboration with the European Heart Rhythm...

July 24, 2013 — St. Jude Medical Inc. announced regulatory approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) and launch of the Accent MRI pacemaker and the Tendril MRI ...

July 15, 2013 — Leonhardt Ventures and Core Manufacturing LLC have announced a new partnership to manufacture and bring to market a lineup of medical technologies.

Sorin Group Reply Pacemakers Sleep Apnea Clinical Study

Sorin Group announced the results of the DREAM clinical trial. In this study, the sleep apnea monitoring (SAM) algorithm of Sorin Reply 200 pacemakers was validated against polysomnography, the...

Boston Scientific Formio Vitalio Inliven Pacemakers EP Lab

Boston Scientific Corporation is launching a new family of pacemakers in Europe. These pacemakers monitor respiration, adjust pacing accordingly, and support insight into the patient's overall...

The incremental mortality in implantable pacemaker and defibrillator recipients who experience a device infection, compared to patients without device infection, is substantial and persists for at...

St. Jude Medical Inc., a global medical device company, has announced first enrollment of its MultiPoint Pacing clinical study to build upon its first- to-market Quadripolar Pacing System....

St. Jude Medical Inc. announced CE Mark approval and European launch of its Allure Quadra Cardiac Resynchronization Therapy Pacemaker (CRT-P). This CRT-P system offers more pacing...

The first patient in the United States has been implanted with the Boston Scientific Corporation ImageReady MR Conditional pacing system in the SAMURAI clinical trial. The study is...